logo
Current Status of Suture-mediated Closure: What Is the Cost of Comfort?
Optimizing Patient Selection in Percutaneous Vertebroplasty
Current Treatment Methods for Postcatheterization Pseudoaneurysms
Radiation Doses in Interventional Radiology Procedures: The RAD-IR Study: Part I: Overall Measures of Dose
Thrombolysis of Acute Peripheral Arterial and Venous Occlusions with Tenecteplase and Eptifibatide: A Pilot Study
Complications of a Percutaneous Suture-mediated Closure Device versus Manual Compression for Arteriotomy Closure: A Case-controlled Study
Complications Associated with Selective High-dose Intraarterial Cisplatin and Concomitant Radiation Therapy for Advanced Head and Neck Cancer
Comparison of the Vasodilating Effect of Nitroglycerin, Verapamil, and Tolazoline in Hand Angiography
Arteriographic and Pathologic Evaluation of Two Suture-mediated Arterial Closure Devices in a Porcine Model
A New Optional Vena Cava Filter: Retrieval at 12 Weeks in an Animal Model
Percutaneous Osteoplasty as a Treatment for Painful Malignant Bone Lesions of the Pelvis and Femur
Fatal Sepsis after Uterine Artery Embolization with Microspheres
Reversal of Flow in the Ovarian Artery during Uterine Artery Embolization
Treatment of Aberrant Right Subclavian Artery Aneurysm with Endovascular Exclusion and Adjunctive Surgical Bypass
Closure of a Ureterocutaneous Fistula with a Covered Stent-Graft
SIR 2003 Film Panel Case 5: Massive Hemorrhage from Portal Vein Disruption
SIR 2003 Film Panel Case 6: Hemosuccus Pancreaticus Secondary to Chronic Pancreatitis
SIR 2003 Film Panel Case 7: Arterial Thoracic Outlet Syndrome Presenting with Upper Extremity Emboli and Posterior Circulation Stroke
SIR 2003 Film Panel Case 8: Aortocaval Fistula Supplied by a Type II Endoleak
11-Year Follow-up of Two Gianturco Z Stents Placed in the Airways of an Infant: A Prospective Analysis of Stent Damage
PERIPHERAL ARTERIAL INTERVENTIONS: Angioplasty
PERIPHERAL ARTERIAL INTERVENTIONS: Stent-Grafts
MESENTERIC INTERVENTIONS
VENOUS INTERVENTIONS
TRAUMA
HEPATOBILIARY
GENITOURINARY
CONTRAST AGENTS
RISK FACTOR MODIFICATION